- Home
- ADUS vs WGS Comparison
ADUS vs WGS Comparison
Compare ADUS & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADUS
- WGS
- Stock Information
- Founded
- ADUS 1979
- WGS 2017
- Country
- ADUS United States
- WGS United States
- Employees
- ADUS 49703
- WGS N/A
- Industry
- ADUS Medical/Nursing Services
- WGS Retail: Computer Software & Peripheral Equipment
- Sector
- ADUS Health Care
- WGS Technology
- Exchange
- ADUS Nasdaq
- WGS Nasdaq
- Market Cap
- ADUS 2.1B
- WGS 2.4B
- IPO Year
- ADUS 2009
- WGS N/A
- Fundamental
- Price
- ADUS $115.29
- WGS $137.28
- Analyst Decision
- ADUS Buy
- WGS Strong Buy
- Analyst Count
- ADUS 10
- WGS 8
- Target Price
- ADUS $140.60
- WGS $130.63
- AVG Volume (30 Days)
- ADUS 177.4K
- WGS 609.2K
- Earning Date
- ADUS 11-03-2025
- WGS 10-28-2025
- Dividend Yield
- ADUS N/A
- WGS N/A
- EPS Growth
- ADUS 6.76
- WGS N/A
- EPS
- ADUS 4.66
- WGS 0.07
- Revenue
- ADUS $1,346,596,000.00
- WGS $402,190,000.00
- Revenue This Year
- ADUS $24.29
- WGS $39.54
- Revenue Next Year
- ADUS $6.62
- WGS $22.50
- P/E Ratio
- ADUS $24.44
- WGS $1,855.34
- Revenue Growth
- ADUS 18.77
- WGS 50.50
- 52 Week Low
- ADUS $88.96
- WGS $55.17
- 52 Week High
- ADUS $136.72
- WGS $147.71
- Technical
- Relative Strength Index (RSI)
- ADUS 45.17
- WGS 56.16
- Support Level
- ADUS $110.00
- WGS $130.00
- Resistance Level
- ADUS $124.44
- WGS $147.71
- Average True Range (ATR)
- ADUS 4.23
- WGS 9.45
- MACD
- ADUS -0.84
- WGS 0.27
- Stochastic Oscillator
- ADUS 24.23
- WGS 56.42
About ADUS Addus HomeCare Corporation
Addus HomeCare Corp is engaged in the provision of in-home personal care services. It operates through the segments such as Personal care segment, which is a key revenue driver, provides non-medical assistance with activities of daily living, mainly to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and their families. Its Home health segment provides services that are medical in nature to those individuals who may require assistance during an illness or after surgery.
About WGS GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.